In the latest case to hit trial over the antipsychotic drug Risperdal, counsel for the drugmaker repeatedly told jurors the plaintiff’s treating physicians knew the risks of the antipsychotic medication, but kept him on the drug because it was “the only thing that ever worked for him.”
Drinker Biddle & Reath attorney David Abernethy made opening statements Monday for Janssen Pharmaceuticals in A.Y. v. Janssen Pharmaceuticals, which is the fifth suit from Philadelphia’s Risperdal-related mass tort program to hit the trial phase. Philadelphia Court of Common Pleas Judge Paula Patrick is presiding over the trial. According to court records, almost 1,750 Risperdal-related lawsuits are pending in Philadelphia.
